Bringing the fundamentals into focus…
Back to Theravance Biopharma Inc
How Theravance Biopharma Inc stacks up
TBPH · against 1,335 other Healthcare companies
Profitability
49/ 100
Below the middle of the pack.
Ranked #676 of 1,336 · scores higher than 49% of peers
Bars: peers in each 10-point band of the profitability score133 peers with a profitability score of 40–49, including TBPH · Click a bar to see the companies
Why profitability scores 49?
Weighted metrics compared with all Healthcare companies.A mix: stronger return on assets, but weaker return on invested capital and operating margin than most Healthcare peers.
- a lower return on invested capital: weaker than 71% of peers. Return on invested capital: -4.7% vs peer median 4.7%
- a thinner operating margin: weaker than 70% of peers. Operating margin: -4.0% vs peer median 7.1%
- a higher return on assets: stronger than 92% of peers. Return on assets: 11.5% vs peer median 1.7%
Metric by metric
Position: dot = TBPH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TBPH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -4.7% | 4.7% | 29% | 33% | |
| Operating marginHigher is better · 1,251 reported | -4.0% | 7.1% | 30% | 33% | |
| Return on assetsHigher is better · 1,315 reported | 11.5% | 1.7% | 92% | 33% | |
| Return on equityHigher is better · 1,252 reported | 20.9% | 3.2% | 90% | Context only | |
| Gross marginHigher is better · 1,394 reported | 75.1% | 45.9% | 83% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around TBPH| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 676 | 3.7B CNY (≈$513M) | 49 | 37 | |
| 676 | 474M USD | 49 | 46 | |
| 676 | 304M EUR (≈$334M) | 49 | 42 | |
| 676 | 3.0B USD | 49 | 39 | |
| 676 | 884M USD | 49 | 75 | |
| 676 | 4.4B AUD (≈$2.9B) | 49 | 51 | |
| 689 | 5.76T KRW (≈$4.1B) | 48 | 59 | |
| 689 | 13.9B CNY (≈$1.9B) | 48 | 29 | |
| 689 | 4.6B CNY (≈$646M) | 48 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score